Pulsed field ablation in atrial fibrillation ablation: where are we and where are we going? [0.03%]
心房颤动导管消融中脉冲电场消融的应用：现状与展望
Marco Schiavone,Claudio Tondo
Marco Schiavone
Pulsed field ablation (PFA) offers a novel approach to treating atrial fibrillation, demonstrating promising efficacy and safety. Unlike traditional thermal ablation techniques like radiofrequency or cryoablation, PFA uses non-thermal irrev...
The role of functional assessment in the management of ischaemic heart disease [0.03%]
缺血性心脏病管理中功能评估的作用
Francesco Prati,Mario Albertucci,Flavio Giuseppe Biccire&#x; et al.
Francesco Prati et al.
Over the past three decades, ischaemia research has been the cornerstone of the management and treatment of patients with atherosclerotic CAD. A robust body of evidence, including non-randomized and randomized trials, has supported the use ...
From thick walls to clear answers: approaches to diagnosing hypertrophic cardiomyopathy and its mimics [0.03%]
从厚心壁到明确诊断：肥厚型心肌病及其拟似病变的诊断方法
Filippo Angelini,Pier Paolo Bocchino,Veronica Dusi et al.
Filippo Angelini et al.
Hypertrophic cardiomyopathy (HCM) is a genetic condition primarily caused by mutations in sarcomeric proteins, leading to abnormal thickening of the left ventricular wall. Although HCM is the most common genetic cardiovascular disorder, oth...
Cardiac involvement in Fabry disease: Recent advances, unresolved issues, and unmet needs [0.03%]
法布里病的心肌病变：最新进展、未决问题及需求缺口
Maurizio Pieroni,Chiara Zocchi,Michele Ciabatti
Maurizio Pieroni
Fabry disease is an X-linked lysosomal storage disorder caused by deficient activity of the enzyme α-galactosidase A, leading to the accumulation of globotriaosylceramide in various tissues, including the heart. Cardiac involvement is a pr...
The 'Padua classification' of cardiomyopathies into three groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic [0.03%]
心肌病的帕多瓦分类分为三组：肥厚型/限制型、扩张型/低动力型和纤维化型/心律失常型
Domenico Corrado,Francesca Graziano,Barbara Bauce et al.
Domenico Corrado et al.
The newly proposed classification of cardiomyopathies, referred to as 'the Padua Classification', is based on both pathobiological basis (genetics, molecular biology, and pathology) and clinical features (morpho-functional and structural ve...
Giovanna Manzi,Tommaso Recchioni,Alexandra Mihai et al.
Giovanna Manzi et al.
The natural history of patients with heart failure (HF), mainly affecting the left ventricle in the initial stages, is marked by the progressive involvement of the right ventricle (RV), which in the advanced stages of the disease becomes di...
Subclinical atrial fibrillation/atrial high-rate episodes: what significance and decision-making? [0.03%]
亚临床心房颤动/心房高率事件：意义和决策？
Giuseppe Boriani,Enrico Tartaglia,Paola Trapanese et al.
Giuseppe Boriani et al.
Subclinical atrial fibrillation (AF) and atrial high-rate episodes (AHREs) are often detected incidentally through cardiac implantable electronic devices or wearables, especially in asymptomatic patients. These episodes pose a clinical chal...
The diagnostic value of electrocardiogram in the left variants of desmosomal arrhythmogenic cardiomyopathy [0.03%]
电图在桥粒型致心律失常性心肌病左侧变异型诊断中的价值
Leonardo Calò,Federica Toto,Germana Panattoni et al.
Leonardo Calò et al.
Electrocardiogram (ECG) may play a crucial role in the diagnosis of left-sided variants of desmosomal arrhythmogenic cardiomyopathies. This article discusses the most common ECG changes, such as T-wave inversion and low QRS voltages, and ne...
SGLT2 inhibitors and new frontiers in heart failure treatment regardless of ejection fraction and setting [0.03%]
SGLT2抑制剂与射血分数和环境无关的心力衰竭治疗新领域
Anna Merlo,Emilia D&#x;Elia,Luca Di Odoardo et al.
Anna Merlo et al.
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have been shown to reduce cardiovascular (CV) mortality and heart failure (HF) hospitalizations, independently from left ventricular ejection fraction (EF). Their efficacy has been assessed...
Implantable cardiac monitor in heart failure: just a toy or a useful tool? [0.03%]
心脏衰竭中植入式心脏监测仪：只是一个玩具还是一个有用的工具？
Francesco Cicogna,Emanuele Canali,Oreste Lanza et al.
Francesco Cicogna et al.
The use of implantable cardiac monitors (ICMs) has gradually entered clinical practice in various fields. In addition to the consolidated indications in the study of syncope, cryptogenic stroke and in the management of patients with arrhyth...